Page 10 - Medicines

Sri Lanka orders release of Rs 1.8 bn from Covid fund to import medicines

Amid Sri Lanka's unprecedented economic crisis, President Gotabaya Rajapaksa has ordered the release of Rs 1.8 billion from Covid-19 healthcare fund for the import of essential medicines

Madurai to Agra, smaller towns witness strong growth in sales of medicines

In terms of launches, around 68% have been in acute therapy in last 12 months, data shows

India likely to extend credit line to Sri Lanka for essential medicines

The quantum of the line of credit to be extended is not yet known

AYUSH ministry's fund utilisation up 25% in 2021-22, sales and exports rise

National AYUSH Mission, the flagship programme, had a shortfall of 16 per cent from budget estimates.

Awareness holds key to success of AYUSH mark, says industry

PM Modi had said that India would soon introduce the AYUSH mark, which will give authenticity to quality AYUSH products of the country.

US drone company Zipline commences delivering medicine in Japan

Zipline, founded six years ago, already is in service in the US, where it has partnered with Walmart Inc. to deliver other products at the retail chain as well as drugs

Medicinal plants await good marketing

Fortunately, India is endowed with a huge and diversified wealth of plant species having curative traits

Market share of Ayush sector has grown 4.6 times since 2016: Sonowal

"The Ayush sector has witnessed phenomenal growth, especially during the pandemic", said Sonowal

Dip in demand for Covid medicines takes a toll on drug sales in March

Covid related drugs contributed 40% of the pharma market last year

India hopes Hyderabad 'pharma city' will break China's grip on industry

India's ability to secure not just its own drug supply but that of Africa, the Americas and Europe is at stake

Bulk of pharma growth came from price hikes, shows data

The average increase in prices was 3.1 per cent in the past five years.

Demand for chronic drugs likely to rise 30% ahead of price hike

There would be a general rise in demand for chronic medicines as consumers would stock up ahead of a price rise

South Korea to send non-lethal military and medical supplies to Ukraine

The South Korean government announced on the 15th that it will send non-lethal military supplies to Ukraine, which is fighting against Russia's invasion

Govt's Jan Aushadi programme to exceed 2021-22 targets, shows data

The pace is slower for including more medicines in the product basket; sales have grown at a CAGR of 51.9% in the last five years

India to send urgent relief supplies, including medicines to Ukraine

Ambassador of India to the United Nations, T S Tirumurti, on Monday said that India has decided to provide urgent relief supplies, including medicines to Ukraine, expected to be dispatched tomorrow

Dolo pill breaks sales record in pandemic as manufacturer makes a fortune

The Covid-19 pandemic has made several healthcare and pharma players billionaires and the makers of Dolo 650

Glenmark Pharma gets tentative FDA nod for generic Regadenoson injection

Glenmark Pharmaceuticals on Monday said its US arm has received tentative approval from the country's health regulator for its generic Regadenoson injection. Regadenoson injection is given during the preparation for a radiologic examination of blood flow through the heart to test for coronary artery disease. The tentative approval granted by the United States Food & Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the company said in a statement. It is the generic version of Lexiscan injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US Inc, it added. Citing IQVIATM sales data for the 12 month period ending November 2021, the company said the Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL) market achieved annual sales of approximately USD 659.9 million. The company said its current portfolio consists of 172 products authorized for distribution in the US marketplace and 47 .

India's diabetes care market to reach $60 bn in next 10 yrs: Report

The diabetes care market in India is expected to reach about $60 billion in the next 10 years, from approximately $17 billion in FY2021, a new report said

Pharma firms to roll out anti-Covid pill as DCGI approves emergency use

Six other homegrown pharma companies announced rolling out their generic versions of the drug shortly

US adds Merck pill as second easy-to-use drug against Covid-19

The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer